148
CHOWBAY, B.; SHARMA, A.; ZHOU, Q.-Y.; CHEUNG, Y. B.; LEE, E. J. D. The
modulation of irinotecan-induced diarrhoea and pharmacokinetics by three different
classes of pharmacologic agents. Oncol. Rep., v. 10, p. 745-51, 2003.
CHU, E. Drug development. In: DEVITA Jr., V. T.; HELLMAN, S.; ROSENBERG, S.
A. Cancer: principles and practice of oncology, pancreatic cancer. 7. ed.
Philadelphia: Lippincott Williams e Wilkins, 2005. cap. 8, s. 1, p. 195-204.
CLANCY, R. M.; AMIN, A. R.; ABRAMSON, S. B. The role of nitric oxide in
inflammation and immunity. Arthritis Rheum., v. 41, n. 7, p.1141-51, 1998.
COOL, J. C.; DYER, J. L.; XIAN, C. J.; BUTLER, R. N.; GEIER, M. S.; HOWARTH, G.
S. Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-
induced intestinal mucositis in rats. Growth Horm. IGF Res., v. 15, p. 72-82, 2005.
CORRAL, L. G.; KAPLAN, G. Immunomodulation by thalidomide and thalidomide
analogues. Ann. Rheum. Dis., v. 58, suppl. 1, p. 1107-13, 1999.
CUNHA, F. Q.; BOUKILI, M. A.; MOTTA, J. I. B., VARGAFTIG, B. B.; FERREIRA, S.
H. Blockade by fenspiride of endotoxin-induced neutrophil migration in the rat. Eur. J.
Pharmacol., v. 238, p. 47-52, 1993.
CWILICH, R. G.; OLVERA, A. S.; PRIETO, A. V. Talidomida en cáncer avanzado:
estudio en fase I. Cir. & Cir., v. 69, n. 2, p. 62-7, 2001.
DAVIES, F. E.; RAJE, N.; HIDESHIMA, T.; LENTZSCH, S.; YOUNG, G.; TAI, Y.-T.;
LIN, B.; PODAR, K.; GUPTA, D.; CHAUHAN, D.; TREON, S. P.; RICHARDSON, P.
G.; SCHLOSSMAN, R. L.; MORGAN, G. J.; MULLER, G. W.; STIRLING, D. I.;
ANDERSON, K. C. Thalidomide and immunomodulatory derivatives augment natural
killer cell cytotoxicity in multiple myeloma. Blood, v. 98, n. 1, 2001.
DE KONING, B. A. E.; VAN DIEREN, J. M.; LINDENBERGH-KORTLEVE, D. J.; VAN
DER SLUIS, M.; MATSUMOTO, T.; YAMAGUCHI, K.; EINERTHAND, A. W.;
SAMSOM, J. N.; PIETERS, R.; NIEUWENHUIS, E. E. S. Contributions of mucosal
immune cells to methotrexate-induced mucositis. Int. Immunol., v. 24, p. 1-9, 2006.
D’HELLENCOURT, C. L.; DIAW, L.; CORNILLET, P.; GUENOUNOU, M. Differential
regulation of TNF-α, IL-1β, IL-6, IL-8, TNF-β e IL-10 by pentoxifylline. Int. J.
Immunopharmac., v. 18, n. 12, p. 739-48, 1996.
DIAZ, A.; CHEPENIK, K. P.; KORN, J. H.; REGINATO, A. M.; JIMENEZ, S. A.
Differential regulation of cyclooxygenases 1 and 2 by interleukin-1β, tumor necrosis
factor-α, and transforming growth factor-β
1 in human lung fibroblasts. Exp. Cell Res.,
v. 241, p. 222-9, 1998.
DIJKSTRA, G.; VAN, G. H.; JANSEN, P. L.; MOSHAGE, H. Targeting nitric oxide in
the gastrointestinal tract. Curr. Opin. Investig. Drugs, v. 5, n. 5, p. 529-36, 2004.